August 2008-Present St. Elizabeths Hospital, Washington, DC
Faculty Member and Attending Psychiatrist
February 2011-Present Renfrew Center, Philadelphia, PA
Providing psychiatric services and covering civil and forensic units as on-call physician. Teach psychiatry residents. Supervise resident morning report on Mondays. Planned, implemented, and overseeing learning portfolio program for residents based on ACGME core competencies for PGY-I, II, & III residents.
September 2005- December 2009 Virginia Commonwealth University, Richmond, VA
Assistant Professor, Department of Psychiatry
Provided psychiatric services in acute inpatient unit at MCV Hospital and geropsychiatric consultation services at multiple nursing homes. Also directed schizophrenia program. Conducted clinical trials at the Mood Disorders Institute and taught residents. Switched to part-time in August 2008.
February 2003-August 2005 National Center for Anxiety, Depression, and Phobias, DC
August 2003-August 2005 Renfrew Center, Philadelphia, PA
Provided psychiatric evaluations and psychopharmacological and psychotherapeutic treatments to a diverse patient population. Specialized in the treatment of depression, anxiety, relationship problems, and eating disorders.
June 2001-August 2005 St. Elizabeths Hospital, Washington, DC
Assistant Director for Psychiatric Services and Clinical Faculty Member
Promoted after acting as the Medical Director for 550-bed hospital. Provided psychopharmacological consultations and in-service training to staff focusing to improve quality of clinical care and readiness for surveys. Also worked as attending psychiatrist and on-call physician. Facilitated psycho-education and support groups. In addition acted as medical director when needed. Supervised and lectured to residents and medical students at various psychiatric topics.
August 1999- May 2001 St. Elizabeths Hospital, Washington, DC
Attending Psychiatrist at the Acute Care Hospital and Clinical Faculty Member
Evaluated acutely mentally ill patients, established diagnosis, and prescribed treatment. Led a multidisciplinary treatment team and provided comprehensive psychiatric care. Trained and supervised psychiatry residents and medical students.
July 1996- June 1999 Yale University School of Medicine, New Haven, CT
Provided inpatient, outpatient, and emergency psychiatric services to children, adults, and geriatric population with various psychiatric, substance abuse, and medical problems. Gained experience in psychotherapy, psychopharmacology, and in leading multidisciplinary treatment teams. Conducted clinical research projects and obtained (22) credits toward an MPH degree from Yale School of Public Health.
July 1995-June 1996 Albany Medical Center, Albany, NY
Internship in Psychiatry, Neurology, Medicine, and Family Medicine
Assessed and treated medical and psychiatric patients with a wide spectrum of pathology. Performed psychiatric, neurological, and physical exams, formulated cases, established diagnoses, and implemented treatments. Presented seminars to peers and faculty.
December 1993-June 1995 Marmara University Hospital, Istanbul, Turkey
Rotating Intern and Resident
Conducted history and physical exams, monitored lab test results, developed differential diagnoses, and designed and implemented treatment plans.
Karadag AS, Bilgili SG, Selvi Y, Tutuncu R, Aydın A, Calka O, Dalkilic A.: Effects of isotretinoin treatment on general psychiatric symptoms, quality of life and social phobia in acne vulgaris patients. Journal of the European Academy of Dermatology and Venereology 2012 Jan 9. doi: 10.1111/j.1468-3083
Karadag, A., Bilgili, S., Selvi, Y., Tutuncu, R., Aydın, A., Calka, O. and Dalkilic, A.: Effectsophrenia. The World Journal of Biological Psychiatry 2009 Sep 4:1-3.
O. Virit, A. Altindag, M. Yumru, A. Dalkilic, H. Savas, S. Selek, O. Erel, H. Herken: A Defect in the Antioxidant Defense System in Schizophrenia. Neuropsychobiology 2009;60:87-93 (DOI: 10.1159/000239684)
Bulut M, Savas HA, Altindag A, Virit O, Dalkilic A.: Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia. The World Journal of Biological Psychiatry. 2009;10(4 Pt 2):626-8.
Pandurangi AK, Dalkilic A.: Polypharmacy with second-generation antipsychotics: a review of evidence. Journal of Psychiatric Practice. 2008 Nov;14(6):345-67
O. Virit, A. Altindag, F. Bulbul, H. Savas, and A. Dalkilic: Long-Acting typical and atypical antipsychotics in treatment of schizophrenia: A retrospective comparison. Bulletin of Clinical Psychopharmacology 2009; vol: 19 number: 2.
Z. Akturk, N. Dagdeviren, C. Özer, and A. Dalkilic: Physical activity patterns of Turkish adolescents: Influence of some social factors. Middle East Journal of Family Medicine, 2004; Vol. 5 (5).
Yorulmaz, F., Dalkilic A. and et al: Smoking among adolescents: Relation to school success, socioeconomic status, nutrition, and self-esteem. Swiss Medical Weekly 2002; 132:449.
Dalkilic A. and et al: Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder. Psychiatric Services 2000; Sep; 51(9): 1184-6.
Dalkilic A. and Grosch W.: Neuroleptic malignant syndrome following initiation of clozapine therapy. American Journal of Psychiatry 1997; 154:881-882.
Dalkilic, A. and et al: Stress and smoking in high school students, was presented & published in 3rd National Public Health Convention, Kayseri, Turkey, 05/93.
In Press: A.S., Karadag, Dalkilic, A., and et al.: Dermatology life quality index in dermal diseases among hospitalized patients. Journal of the Turkish Academy of Dermatology 2012.
A. Dalkilic: Psychopharmacological treatments in eating disorders. Platform presentation at TAP 4th International Congress on Psychopharmacology, November 23-27, 2011, Antalya, Turkey.
A. Dalkilic: Transcultural psychiatry: Practice and sample cases in USA & status in Turkey. Platform presentation at TAP 4th International Congress on Psychopharmacology, November 23-27, 2011, Antalya, Turkey.
A. Dalkilic, E. Burakgazi, J. French: Psychiatric Comorbidity and Psychotropic Medication Use in Epilepsy Patients. Poster presentation at 62nd Annual Meeting of the American Epilepsy Society, December 5–9, 2008, Seattle, WA.
S. B. Barker, A. Dalkilic, J. Knisely, C. Schubert, and the AAT Study Group: Stress Response to Interacting with a Therapy Dog: An Exploratory Study, International Society of Anthrozoology Conference, August 13-15, 2008.
A. Dalkilic, MD, A. Pandurangi: Atypical Antipsychotic Polypharmacy: A Review of Evidence, Poster presentation at 10th Annual Future Leaders in Psychiatry Meeting, Orlando, FL organized by Emory University May 22-25, 2008.
Research, Clinical Trial, & Other
October 1, 2005-January 15 2008 Co-Investigator, Obesity and body image in psychosis study, VCU Health System
March 2007-August 2008 Collaborated with S. Barker, PhD, A. Pandurangi, MD, and others on “Quantative EEG Changes in Healthy Volunteers due to Interaction with Therapy Dogs”
June 1, 2006- September 1 , 2007 Co-Investigator, Predicting Response to Risperidone Treatment, VCU Health System
July 1, 2006- December 31, 2009 Co-Investigator, Multiple Clinical Trials, VCU Mood Disorders Institute (MDI):
- Randomized, double-blind comparison of duloxetine 30mg qd and placebo in adult patients with fibromyalgia.
- Double-blind, placebo-controlled study of cariprazine as adjunctive therapy in MDD.
- Double-blind fixed dose study of escitalopram MR in adult patients with MDD.
- 24-week randomized, double-blind, placebo-controlled safety and efficacy trial of flibanserin 50mg daily and with uptitration 100mg daily in premenopausal women with hypoactive sexual desire disorder.
- Symptom-onset antidepressant treatment for PMDD.
- Duloxetine versus placebo in patients with MDD: Assessment of energy and vitality in MDD.
- 8-week, multicentre, randomized, double-blind, placebo-and-paroxetine controlled study of the efficacy, safety, and tolerability of agomelatine 25 or 50mg daily for MDD.
- Multi-center, randomized, 8-week, double-blind, acute phase study followed by a 6-month continuation phase study to evaluate the efficacy, safety, and tolerability of DVS SR in post-menopausal women with MDD.
- Multi-center, randomized, 8-week, double-blind, placebo-controlled study followed by a 6-month open-label extension to evaluate the efficacy and safety of DVS SR in peri- and post-menopausal women with MDD.
- Fixed dose comparison of escitalopram to active comparator in moderately-to-severely depressed patients.
- Multi-center, randomized double-blind, placebo-controlled study of a combination of levonorgestrel and ethinyl estradiaol in subjects with PMDD.
Honors & Awards
May 2008 was nominated & selected to participate in 10th Annual Future Leaders in Psychiatry Conference by Emory University
2003 Secured “Partners for Excellence in Psychiatry” Grant from University of Medicine and Dentistry of New Jersey (UMDNJ) for St. Elizabeths Hospital
1993 Ranked among top 0.5% out of 20,000 physicians in Nationwide Residency Training Entrance Exam of Turkey
1990-1993 Elected Student Representative for three consecutive terms, Marmara University School of Medicine
1986-1993 Recipient, Government Scholarship
1991-1993 Recipient, Sandoz Inc. Scholarship for Academic Merit
1990-1992 Recipient, Association of Turkish Mothers Academic Merit Scholarship
1989 Recipient, International Federation of Medical Student Association Scholarship
1986 Ranked in top 2% out of a half million applicants Nationwide College Entrance Exam of Turkey
VCU PGY-II Didactic Series: Mood Disorders (4 lectures, September 2007- August 2008)
VCU PGY-I Didactic Series: Practical Psychopharmacology (2 lectures, September 2006-August 2008)
Hands-on clinical knowledge and skills training for a PGY-I or II residents and medical students during schizophrenia team rotations at VCU (September 2005-August 2008) and during on call duty at St. Elizabeths Hospital.